K. Vekemans

3.0k total citations · 2 hit papers
24 papers, 2.1k citations indexed

About

K. Vekemans is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, K. Vekemans has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Radiation. Recurrent topics in K. Vekemans's work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (19 papers) and Bladder and Urothelial Cancer Treatments (6 papers). K. Vekemans is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (19 papers) and Bladder and Urothelial Cancer Treatments (6 papers). K. Vekemans collaborates with scholars based in Belgium, Netherlands and France. K. Vekemans's co-authors include Laurence Collette, Hendrik Van Poppel, M. Bolla, L. Da Pozzo, Jean-François Bosset, A. Verbaeys, Karin Haustermans, Theo M. de Reijke, Paul Van Cangh and Pierre Scalliet and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

K. Vekemans

24 papers receiving 2.1k citations

Hit Papers

Postoperative radiotherapy after radical prostatectomy: a... 2005 2026 2012 2019 2005 2012 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
    2005 835 citations M. Bolla, Hendrik Van Poppel et al. The Lancet profile →
  2. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
    2012 560 citations M. Bolla, Hendrik Van Poppel et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Vekemans Belgium 14 1.9k 536 436 318 214 24 2.1k
A. Verbaeys Belgium 12 1.8k 0.9× 637 1.2× 365 0.8× 300 0.9× 118 0.6× 36 1.9k
Paul Van Cangh Belgium 13 1.5k 0.8× 352 0.7× 432 1.0× 418 1.3× 158 0.7× 34 2.0k
David S. Lamb New Zealand 15 1.4k 0.7× 350 0.7× 120 0.3× 181 0.6× 232 1.1× 40 1.6k
Tony Crispino United States 11 1.5k 0.8× 84 0.2× 245 0.6× 279 0.9× 321 1.5× 16 1.7k
A.V. D’Amico United States 7 812 0.4× 121 0.2× 157 0.4× 157 0.5× 119 0.6× 16 924
John Matthews Australia 14 755 0.4× 256 0.5× 73 0.2× 143 0.4× 149 0.7× 25 1.0k
Kenneth R. Blank United States 10 669 0.3× 88 0.2× 137 0.3× 200 0.6× 174 0.8× 18 967
Mark H. Leibenhaut United States 14 1.0k 0.5× 183 0.3× 60 0.1× 205 0.6× 413 1.9× 27 1.3k
Brian F. Chapin United States 22 1.5k 0.8× 67 0.1× 235 0.5× 271 0.9× 406 1.9× 116 1.9k
Holger Borchers Germany 20 681 0.4× 180 0.3× 107 0.2× 211 0.7× 150 0.7× 58 930

Countries citing papers authored by K. Vekemans

Since Specialization
Citations

This map shows the geographic impact of K. Vekemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Vekemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Vekemans more than expected).

Fields of papers citing papers by K. Vekemans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Vekemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Vekemans. The network helps show where K. Vekemans may publish in the future.

Co-authorship network of co-authors of K. Vekemans

This figure shows the co-authorship network connecting the top 25 collaborators of K. Vekemans. A scholar is included among the top collaborators of K. Vekemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Vekemans. K. Vekemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goossens, Maria E., Maurice P. Zeegers, Hendrik Van Poppel, et al.. (2016). Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial. European Journal of Cancer. 69. 9–18. 17 indexed citations
2.
Bolla, M., Hendrik Van Poppel, Bertrand Tombal, et al.. (2012). Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). The Lancet. 380(9858). 2018–2027. 560 indexed citations breakdown →
3.
Buntinx, Frank, Steven Joniau, Koen Ackaert, et al.. (2012). Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium. BMC Urology. 12(1). 8–8. 13 indexed citations
4.
Poppel, Hendrik Van, M. Bolla, Bertrand Tombal, et al.. (2011). 227 ADJUVANT RADIOTHERAPY AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICALLY HIGH RISK PROSTATE CANCER: 10-YEAR FOLLOW-UP RESULTS. European Urology Supplements. 10(2). 93–93. 8 indexed citations
5.
Budiharto, Tom, Christiaan Perneel, Karin Haustermans, et al.. (2010). A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. Radiotherapy and Oncology. 97(3). 474–479. 23 indexed citations
6.
Bolla, M., Hendrik Van Poppel, Bertrand Tombal, et al.. (2010). 10-year Results of Adjuvant Radiotherapy after Radical Prostatectomy in pT3N0 Prostate Cancer (EORTC 22911). International Journal of Radiation Oncology*Biology*Physics. 78(3). S29–S29. 11 indexed citations
7.
Verhulst, Stijn, K. Vekemans, Erwin Ho, et al.. (2007). Is wheezing associated with decreased sleep quality in Sri Lankan children? A questionnaire study. Pediatric Pulmonology. 42(7). 579–583. 15 indexed citations
8.
Kwast, Theodorus van der, M. Bolla, Hendrik Van Poppel, et al.. (2007). Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911. Journal of Clinical Oncology. 25(27). 4178–4186. 204 indexed citations
9.
Bolla, M., Hendrik Van Poppel, Laurence Collette, et al.. (2006). Postoperative Radiotherapy After Radical Prostatectomy: A Randomised Controlled Trial (EORTC Trial 22911). The Journal of Urology. 175(5). 1707–1708. 32 indexed citations
10.
Kwast, Theodorus van der, Laurence Collette, Hendrik Van Poppel, et al.. (2006). Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(4). 428–434. 68 indexed citations
11.
Kwast, Theodorus van der, M Bolla, Hendrik Van Poppel, et al.. (2006). 1391: Gleason Score and Margin Status are the Strongest Predictors for Benefit of Radiotherapy after Radical Prostatectomy. The Journal of Urology. 175(4S). 449–449. 1 indexed citations
12.
Kwast, Theodorus van der, M. Bolla, Hendrik Van Poppel, et al.. (2006). IMPACT OF PATHOLOGICAL REVIEW OF RADICAL PROSTATECTOMY SPECIMENS ON PROGNOSIS AND PREDICTED BENEFIT FROM IMMEDIATE POSTOPERATIVE IRRADIATION FOR HIGH-RISK PATIENTS (EORTC 22911). European Urology Supplements. 5(2). 205–205. 2 indexed citations
13.
Poppel, Hendrik Van, K. Vekemans, L. Da Pozzo, et al.. (2006). Radical prostatectomy for locally advanced prostate cancer: Results of a feasibility study (EORTC 30001). European Journal of Cancer. 42(8). 1062–1067. 53 indexed citations
14.
Bolla, M., Hendrik Van Poppel, Laurence Collette, et al.. (2005). EORTC trial 22911: Immediate post-prostatectomy irradiation improves biochemical and clinical progression-free survival in patients with pathologically high risk prostate cancer. European Journal of Cancer Supplements. 3(2). 230–230. 1 indexed citations
15.
Sternberg, Cora N., Peter Whelan, John Hetherington, et al.. (2005). Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer. Oncology. 68(1). 2–9. 167 indexed citations
16.
Collette, Laurence, Hendrik Van Poppel, M. Bolla, et al.. (2005). Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). European Journal of Cancer. 41(17). 2662–2672. 53 indexed citations
17.
Bolla, M., Hendrik Van Poppel, Laurence Collette, et al.. (2005). Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). The Lancet. 366(9485). 572–578. 835 indexed citations breakdown →
18.
Poppel, H. Van, M Bolla, Paul Van Cangh, et al.. (2003). Is immediate post-operative radiation of pT3NO prostate cancer a safe treatment? Results of EORTC-trial 22911.. The Journal of Urology. 169(4). 492–492. 2 indexed citations
19.
Poppel, Hendrik Van, M. Bolla, K. Vekemans, et al.. (2003). How severe is acute and late toxicity of post-operative radiation treatment for PT3N0 prostate cancer? EORTC trial 22911. European Urology Supplements. 2(1). 154–154. 1 indexed citations
20.
Bolla, M., Hendrik Van Poppel, Paul J. Van Cangh, et al.. (2002). Acute and late toxicity of post-operative external irradiation in pT3N0 prostate cancer patients treated within EORTC trial 22911. International Journal of Radiation Oncology*Biology*Physics. 54(2). 62–63. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Verbaeys Breakdown of academic impact, for papers by Paul Van Cangh Breakdown of academic impact, for papers by David S. Lamb Breakdown of academic impact, for papers by Tony Crispino Breakdown of academic impact, for papers by A.V. D’Amico Breakdown of academic impact, for papers by John Matthews Breakdown of academic impact, for papers by Kenneth R. Blank Breakdown of academic impact, for papers by Mark H. Leibenhaut Breakdown of academic impact, for papers by Brian F. Chapin Breakdown of academic impact, for papers by Holger Borchers
Rankless by CCL
2026